Across TCGA pan-cancer cohorts, RPS12P5 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPS12P5’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPS12P5 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS12P5 is over-expressed in tumor, although a few such as STAD and THCA show the opposite, repressed pattern.

STAD and THCA are the cancer types where RPS12P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS12P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	−0.181	.013	2	view →
THCA	All	All	−0.083	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPS12P5 RNA expression & survival · all RPS12P5 data types